Voyager Therapeutics, Inc. (VYGR) Operating margin 2016–2025
Voyager Therapeutics, Inc. (VYGR) operating margin by fiscal year — reported operating income divided by reported revenue.
-326.6%FY2025 · since FY2016: -290.4% → -326.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -326.6% | -222.4 pp |
| FY2024 | -104.1% | -152.9 pp |
| FY2023 | 48.8% | +173.1 pp |
| FY2022 | -124.3% | +72.5 pp |
| FY2021 | -196.8% | -212.8 pp |
| FY2020 | 16.0% | +65.5 pp |
| FY2019 | -49.5% | +1146.1 pp |
| FY2018 | -1195.6% | -486.6 pp |
| FY2017 | -709.1% | -418.6 pp |
| FY2016 | -290.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice